OPTIMIZING THE TREATMENT OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASE WITH LERCANIDIPINE

<p>Comorbidity of cardiovascular diseases reciprocally aggravates their course and induces the need to use safety and well-tolerated drugs. Pharmacological and pharmacokinetic properties of lercanidipine – the third-generation calcium channel blocker – are characterized by high lipophilicity a...

Full description

Bibliographic Details

Published in:	Рациональная фармакотерапия в кардиологии
Main Author:	E. L. Trisvetova
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-09-01
Subjects:	сердечно-сосудистые заболевания антигипертензивное лечение блокаторы кальциевых каналов лерканидипин
Online Access:	http://www.rpcardio.ru/jour/article/view/262